SitesBLAST
Comparing WP_094932740.1 NCBI__GCF_002263495.1:WP_094932740.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
4hcxA Structure of icdh-1 from m.Tuberculosis complexed with NADPH & mn2+ (see paper)
78% identity, 99% coverage: 3:402/405 of query aligns to 2:401/402 of 4hcxA
- binding manganese (ii) ion: D274 (= D275), D278 (= D279)
- binding nadph dihydro-nicotinamide-adenine-dinucleotide phosphate: A73 (= A74), T74 (= T75), T76 (= T77), E305 (= E306), H308 (= H309), G309 (= G310), T310 (= T311), V311 (= V312), R313 (= R314), H314 (= H315), N327 (= N328)
O88844 Isocitrate dehydrogenase [NADP] cytoplasmic; IDH; IDH1; Cytosolic NADP-isocitrate dehydrogenase; IDPc; NADP(+)-specific ICDH; Oxalosuccinate decarboxylase; EC 1.1.1.42 from Mus musculus (Mouse) (see paper)
69% identity, 98% coverage: 10:405/405 of query aligns to 10:410/414 of O88844
- TIT 75:77 (= TIT 75:77) binding NADP(+)
- T77 (= T77) binding in other chain
- R82 (= R82) binding NADP(+)
- 94:100 (vs. 94:100, 100% identical) binding in other chain
- R109 (= R109) binding in other chain
- R132 (= R132) binding in other chain
- K212 (= K212) binding substrate
- C245 (≠ T245) mutation to S: No effect on inhibition by cadmium ions.
- K260 (= K260) binding NADP(+)
- GTVTRH 310:315 (= GTVTRH 310:315) binding NADP(+)
- N328 (= N328) binding NADP(+)
- C379 (≠ L379) mutation to S: Decreased inhibition by cadmium ions.
5yziA Crystal structure of mouse cytosolic isocitrate dehydrogenase complexed with cadmium (see paper)
69% identity, 98% coverage: 10:405/405 of query aligns to 7:407/409 of 5yziA
- binding cadmium ion: D272 (= D275), D276 (= D279)
- binding nadp nicotinamide-adenine-dinucleotide phosphate: T72 (= T75), T74 (= T77), N93 (= N96), H306 (= H309), G307 (= G310), T308 (= T311), V309 (= V312), T310 (= T313), R311 (= R314), H312 (= H315), T324 (= T327), N325 (= N328)
1t09A Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase in complex NADP (see paper)
67% identity, 100% coverage: 1:405/405 of query aligns to 1:410/414 of 1t09A
- binding nadp nicotinamide-adenine-dinucleotide phosphate: A74 (= A74), T75 (= T75), I76 (= I76), T77 (= T77), R82 (= R82), N96 (= N96), D279 (= D279), S280 (≠ T280), H309 (= H309), G310 (= G310), V312 (= V312), R314 (= R314), T327 (= T327), N328 (= N328)
O75874 Isocitrate dehydrogenase [NADP] cytoplasmic; IDH; IDH1; Cytosolic NADP-isocitrate dehydrogenase; IDPc; NADP(+)-specific ICDH; Oxalosuccinate decarboxylase; EC 1.1.1.42 from Homo sapiens (Human) (see 6 papers)
67% identity, 100% coverage: 1:405/405 of query aligns to 1:410/414 of O75874
- TIT 75:77 (= TIT 75:77) binding NADP(+)
- T77 (= T77) binding in other chain
- R82 (= R82) binding NADP(+)
- 94:100 (vs. 94:100, 100% identical) binding in other chain
- R109 (= R109) binding in other chain
- R132 (= R132) binding in other chain; to C: in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; found in patients with cartilaginous tumors; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate; induces histone methylation; enhances expression of chondrocyte-related genes; disturbs the formation of cartilaginous matrix; inhibits osteogenic differentiation; dbSNP:rs121913499; to G: in a glioma sample; glioblastoma multiforme; somatic mutation; found in patients with cartilaginous tumors; dbSNP:rs121913499; to H: in a glioma sample; glioblastoma multiforme; somatic mutation; found in patients with cartilaginous tumors; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate; dbSNP:rs121913500; to L: in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate; dbSNP:rs121913500; to S: in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate; dbSNP:rs121913499
- K212 (= K212) binding substrate
- K260 (= K260) binding NADP(+)
- GTVTRH 310:315 (= GTVTRH 310:315) binding NADP(+)
- N328 (= N328) binding NADP(+)
6bkxA Novel modes of inhibition of wild-type idh1: direct covalent modification of his315 with cmpd1 (see paper)
68% identity, 98% coverage: 10:405/405 of query aligns to 8:408/414 of 6bkxA
- binding calcium ion: D273 (= D275), D277 (= D279)
- binding (6aS,7S,9R,10aS)-7,10a-dimethyl-8-oxo-2-(phenylamino)-5,6,6a,7,8,9,10,10a-octahydrobenzo[h]quinazoline-9-carbonitrile: H307 (= H309), V310 (= V312), R312 (= R314), H313 (= H315), S324 (= S326), K372 (= K374), D373 (= D375)
6bl2A Novel modes of inhibition of wild-type idh1: direct covalent modification of his315 with cmpd15 (see paper)
68% identity, 98% coverage: 10:405/405 of query aligns to 8:408/416 of 6bl2A
- binding 3-[(6aS,7S,9S,10aS)-9-cyano-7-methyl-8-oxo-2-(phenylamino)-6,6a,7,8,9,10-hexahydrobenzo[h]quinazolin-10a(5H)-yl]benzoic acid: H307 (= H309), V310 (= V312), R312 (= R314), H313 (= H315), T323 (= T325), K372 (= K374), D373 (= D375), A376 (≠ L378), L381 (vs. gap)
6bl1A Novel modes of inhibition of wild-type idh1: direct covalent modification of his315 with cmpd13 (see paper)
68% identity, 98% coverage: 10:405/405 of query aligns to 8:408/416 of 6bl1A
- binding calcium ion: D273 (= D275), D277 (= D279)
- binding (6aS,7S,9S,10aS)-7-methyl-8-oxo-10a-phenyl-2-(phenylamino)-5,6,6a,7,8,9,10,10a-octahydrobenzo[h]quinazoline-9-carbonitrile: H307 (= H309), V310 (= V312), R312 (= R314), H313 (= H315), M316 (≠ Q318), K372 (= K374), L381 (vs. gap)
6bl0A Novel modes of inhibition of wild-type idh1:direct covalent modification of his315 with cmpd11 (see paper)
68% identity, 98% coverage: 10:405/405 of query aligns to 8:408/416 of 6bl0A
- binding (5aS,6S,8S,9aS)-2-(benzenecarbonyl)-6-methyl-7-oxo-9a-phenyl-4,5,5a,6,7,8,9,9a-octahydro-2H-benzo[g]indazole-8-carbonitrile: H307 (= H309), V310 (= V312), R312 (= R314), H313 (= H315), N326 (= N328), K372 (= K374), L381 (vs. gap)
6bkyA Novel binding modes of inhibition of wild-type idh1: allosteric inhibition with cmpd2 (see paper)
68% identity, 98% coverage: 10:405/405 of query aligns to 8:408/416 of 6bkyA
6bkzA Novel modes of inhibition of wild-type idh1: non-equivalent allosteric inhibition with cmpd3 (see paper)
68% identity, 98% coverage: 10:405/405 of query aligns to 8:408/412 of 6bkzA
- binding (7R)-1-[(4-fluorophenyl)methyl]-N-{3-[(1R)-1-hydroxyethyl]phenyl}-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide: A109 (≠ P111), I111 (= I113), L118 (= L120), L118 (= L120), W122 (= W124), I126 (= I128), M257 (≠ L259), M257 (≠ L259), W265 (= W267), V274 (= V276), V279 (= V281), A280 (= A282), G282 (= G284), Y283 (≠ F285)
- binding nadp nicotinamide-adenine-dinucleotide phosphate: T73 (= T75), I74 (= I76), T75 (= T77), N94 (= N96), S285 (= S287), H307 (= H309), G308 (= G310), T309 (= T311), V310 (= V312), R312 (= R314), H313 (= H315), T325 (= T327), N326 (= N328), D373 (= D375)
5yfmA Human isocitrate dehydrogenase 1 bound with NADP
68% identity, 98% coverage: 10:405/405 of query aligns to 8:408/409 of 5yfmA